Analyst Ratings for Ionis Pharmaceuticals (IONS) [Neutrals]

All Latest Ratings for IONS

IONS Rating Summary

IONS Price Target Summary

* Over Last 12-Mos
  |   Expand Research on IONS
Overall Rating: NEUTRAL   Rating Trend: =   Avg. $ Target: $59.04 (+61.6%) * Over Last 12-Mos
Rating Score: 4 / 10   Percentile Rank: 37%
Date Firm Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
5/7/2021 UBS Esther Rajavelu Upgrade Neutral
(Sell)		 37.50
(33.00)		 39.89
(36.54)		 -8.4% Details
3/1/2021 Barclays
» Updated 3/23/2021		 Gena Wang Upgrade Equalweight
(Underweight)		 47.00
(52.00)		 53.41
(36.54)		 -31.59% Details
Like IONS Ratings? Also take a look at AKCA, BIIB, ACCD, PFE

IONS Ratings News